No Data
Sawai to Retire 16 Million Shares
List of conversion stocks (part 3) [Parabolic Cigna Corp conversion stocks list]
○ List of Stocks Turning to Sell in the Market Code Stock Name Closing Price SAR Tokyo Main Board <4206> Aica Kogyo 3297 3468 <4218> Nichiban 20082155 <4229> GunEi Chemical 29843095 <4323> Nissys Technology 18051911 <4333> Toho System 12361294 <4337> Pia 26472940 <4345> CTS Corp 772813 <4362>
Sawai GHD inherits the rights to warfarin tablets in the country.
On the 27th, Sawai GHD <4887.T> announced that the group's Sawai Pharmaceutical has signed a contract to inherit the rights to the pharmaceutical product Warfarin Tablets (generic name: Warfarin Potassium), manufactured and sold by Eisai <4523.T> in Japan. The oral anticoagulant "Warfarin" has been used for a long time in the treatment and prevention of many patients with thromboembolic diseases. With the conclusion of the contract, the company will pay Eisai 45 as compensation for the transfer.
Sawai Group Holdings To Go Ex-Dividend On March 28th, 2025 With 27 JPY Dividend Per Share
March 27th (Japan Standard Time) - $Sawai Group Holdings(4887.JP)$ is trading ex-dividend on March 28th, 2025.Shareholders of record on March 31st, 2025 will receive 27 JPY dividend per share. The ex-
Sawai Group Holdings to Enhance Governance With New Supervisory Committee
Express News | [Change Report] Silchester International reports a decrease in its shareholding of Sawai Group Holdings (4887.JP) to 5.72%.